In addition, it is worth noting that SCLC has the ability to transdifferentiate from lung adenocarcinoma (LUAD) when certain driver mutations, like epidermal growth factor receptor (EGFR), are lost [10]. This evidence concerns the gene EGFR and lung adenocarcinoma.